AUD 0.02
(-7.69%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | - AUD | -100.0% |
2023 | 11.77 Million AUD | -9.19% |
2022 | 12.96 Million AUD | 79.35% |
2021 | 7.23 Million AUD | 74.94% |
2020 | 4.13 Million AUD | 0.16% |
2019 | 4.12 Million AUD | 124.21% |
2018 | 1.84 Million AUD | 58.14% |
2017 | 1.16 Million AUD | -25.59% |
2016 | 1.56 Million AUD | 144.92% |
2015 | 638.67 Thousand AUD | 18.64% |
2014 | 538.31 Thousand AUD | 159.78% |
2013 | 207.22 Thousand AUD | -12.16% |
2012 | 235.91 Thousand AUD | -89.41% |
2011 | 2.22 Million AUD | 0.0% |
2010 | - AUD | 0.0% |
2009 | - AUD | 0.0% |
2008 | - AUD | -100.0% |
2007 | 374.56 Thousand AUD | 0.0% |
2006 | - AUD | 0.0% |
2005 | - AUD | 0.0% |
2004 | - AUD | -100.0% |
2003 | 19.00 AUD | -100.0% |
2002 | 1.29 Million AUD | 1030.78% |
2001 | 114.23 Thousand AUD | 0.0% |
2000 | - AUD | 0.0% |
1999 | - AUD | 0.0% |
1998 | - AUD | -100.0% |
1997 | 3.85 Million AUD | 1288.13% |
1996 | 278 Thousand AUD | 47.87% |
1995 | 188 Thousand AUD | 0.0% |
1994 | - AUD | 0.0% |
1993 | - AUD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q4 | - AUD | 0.0% |
2024 FY | - AUD | -100.0% |
2024 Q2 | 8.06 Million AUD | 0.0% |
2023 FY | 11.77 Million AUD | -9.19% |
2023 Q4 | 6.96 Million AUD | 0.0% |
2023 Q2 | 4.81 Million AUD | 0.0% |
2022 Q4 | 7.62 Million AUD | 0.0% |
2022 FY | 12.96 Million AUD | 79.35% |
2022 Q2 | 5.34 Million AUD | 0.0% |
2021 FY | 7.23 Million AUD | 74.94% |
2021 Q2 | 4.08 Million AUD | 0.0% |
2021 Q4 | 3.14 Million AUD | 0.0% |
2020 Q2 | 2.37 Million AUD | 0.0% |
2020 FY | 4.13 Million AUD | 0.16% |
2020 Q4 | 1.75 Million AUD | 0.0% |
2019 Q2 | 1.62 Million AUD | 0.0% |
2019 FY | 4.12 Million AUD | 124.21% |
2019 Q4 | 2.5 Million AUD | 0.0% |
2018 Q2 | 698.35 Thousand AUD | 0.0% |
2018 FY | 1.84 Million AUD | 58.14% |
2018 Q4 | 1.14 Million AUD | 0.0% |
2017 Q2 | 769.09 Thousand AUD | 0.0% |
2017 FY | 1.16 Million AUD | -25.59% |
2017 Q4 | 394.95 Thousand AUD | 0.0% |
2016 FY | 1.56 Million AUD | 144.92% |
2016 Q4 | 927.91 Thousand AUD | 0.0% |
2016 Q2 | 636.35 Thousand AUD | 0.0% |
2015 Q2 | 482 Thousand AUD | 0.0% |
2015 FY | 638.67 Thousand AUD | 18.64% |
2015 Q4 | 156.67 Thousand AUD | 0.0% |
2014 Q2 | 6827.00 AUD | 0.0% |
2014 FY | 538.31 Thousand AUD | 159.78% |
2014 Q4 | 531.48 Thousand AUD | 0.0% |
2013 Q3 | - AUD | -100.0% |
2013 Q4 | 192.34 Thousand AUD | 0.0% |
2013 Q2 | 14.87 Thousand AUD | -74.79% |
2013 Q1 | 58.97 Thousand AUD | 0.0% |
2013 FY | 207.22 Thousand AUD | -12.16% |
2012 FY | 235.91 Thousand AUD | -89.41% |
2012 Q4 | 58.97 Thousand AUD | 0.0% |
2012 Q3 | 58.97 Thousand AUD | 0.0% |
2012 Q2 | 58.97 Thousand AUD | -89.41% |
2012 Q1 | 556.75 Thousand AUD | 0.0% |
2011 FY | 2.22 Million AUD | 0.0% |
2011 Q4 | 556.75 Thousand AUD | 0.0% |
2011 Q3 | 556.75 Thousand AUD | 0.0% |
2011 Q2 | 556.75 Thousand AUD | 0.0% |
2011 Q1 | - AUD | 0.0% |
2010 Q1 | - AUD | 0.0% |
2010 Q2 | - AUD | 0.0% |
2010 Q4 | - AUD | 0.0% |
2010 Q3 | - AUD | 0.0% |
2010 FY | - AUD | 0.0% |
2009 Q2 | - AUD | 0.0% |
2009 Q4 | - AUD | 0.0% |
2009 Q3 | - AUD | 0.0% |
2009 FY | - AUD | 0.0% |
2009 Q1 | - AUD | 0.0% |
2008 Q1 | 393.00 AUD | 0.0% |
2008 FY | - AUD | -100.0% |
2008 Q4 | - AUD | 0.0% |
2008 Q3 | - AUD | 0.0% |
2008 Q2 | - AUD | -100.0% |
2007 Q2 | 393.00 AUD | 0.0% |
2007 Q4 | 393.00 AUD | 0.0% |
2007 FY | 374.56 Thousand AUD | 0.0% |
2007 Q1 | - AUD | 0.0% |
2007 Q3 | 393.00 AUD | 0.0% |
2006 Q3 | - AUD | 0.0% |
2006 FY | - AUD | 0.0% |
2006 Q4 | - AUD | 0.0% |
2006 Q2 | - AUD | 0.0% |
2006 Q1 | - AUD | 0.0% |
2005 FY | - AUD | 0.0% |
2005 Q4 | - AUD | 0.0% |
2005 Q1 | - AUD | 0.0% |
2005 Q3 | - AUD | 0.0% |
2005 Q2 | - AUD | 0.0% |
2004 FY | - AUD | -100.0% |
2004 Q3 | - AUD | 0.0% |
2004 Q2 | - AUD | -100.0% |
2004 Q1 | 4.75 AUD | 0.0% |
2004 Q4 | - AUD | 0.0% |
2003 Q4 | 4.75 AUD | 0.0% |
2003 FY | 19.00 AUD | -100.0% |
2003 Q3 | 4.75 AUD | 0.0% |
2003 Q1 | 322.94 Thousand AUD | 0.0% |
2003 Q2 | 4.75 AUD | -100.0% |
2002 Q1 | 28.55 Thousand AUD | 0.0% |
2002 Q3 | 322.94 Thousand AUD | 0.0% |
2002 FY | 1.29 Million AUD | 1030.78% |
2002 Q2 | 322.94 Thousand AUD | 1030.81% |
2002 Q4 | 322.94 Thousand AUD | 0.0% |
2001 Q1 | - AUD | 0.0% |
2001 Q3 | 28.55 Thousand AUD | 0.0% |
2001 Q4 | 28.55 Thousand AUD | 0.0% |
2001 FY | 114.23 Thousand AUD | 0.0% |
2001 Q2 | 28.55 Thousand AUD | 0.0% |
2000 Q2 | - AUD | 0.0% |
2000 Q4 | - AUD | 0.0% |
2000 Q3 | - AUD | 0.0% |
2000 FY | - AUD | 0.0% |
2000 Q1 | - AUD | 0.0% |
1999 Q4 | - AUD | 0.0% |
1999 Q2 | - AUD | 0.0% |
1999 Q3 | - AUD | 0.0% |
1999 Q1 | - AUD | 0.0% |
1999 FY | - AUD | 0.0% |
1998 Q2 | - AUD | -100.0% |
1998 Q3 | - AUD | 0.0% |
1998 Q1 | 964.75 Thousand AUD | 0.0% |
1998 Q4 | - AUD | 0.0% |
1998 FY | - AUD | -100.0% |
1997 Q3 | 964.75 Thousand AUD | 0.0% |
1997 FY | 3.85 Million AUD | 1288.13% |
1997 Q4 | 964.75 Thousand AUD | 0.0% |
1997 Q2 | 964.75 Thousand AUD | 1288.13% |
1997 Q1 | 69.5 Thousand AUD | 0.0% |
1996 Q4 | 69.5 Thousand AUD | 0.0% |
1996 Q3 | 69.5 Thousand AUD | 0.0% |
1996 FY | 278 Thousand AUD | 47.87% |
1996 Q2 | 69.5 Thousand AUD | 47.87% |
1996 Q1 | 47 Thousand AUD | 0.0% |
1995 FY | 188 Thousand AUD | 0.0% |
1995 Q1 | - AUD | 0.0% |
1995 Q2 | 47 Thousand AUD | 0.0% |
1995 Q3 | 47 Thousand AUD | 0.0% |
1995 Q4 | 47 Thousand AUD | 0.0% |
1994 Q4 | - AUD | 0.0% |
1994 Q2 | - AUD | 0.0% |
1994 Q3 | - AUD | 0.0% |
1994 FY | - AUD | 0.0% |
1994 Q1 | - AUD | 0.0% |
1993 Q4 | - AUD | 0.0% |
1993 FY | - AUD | 0.0% |
1993 Q2 | - AUD | 0.0% |
1993 Q3 | - AUD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AdAlta Limited | 1.73 Million AUD | 100.0% |
Acrux Limited | 5.09 Million AUD | 100.0% |
Actinogen Medical Limited | 9.93 Million AUD | 100.0% |
AnteoTech Limited | 460.39 Thousand AUD | 100.0% |
Argenica Therapeutics Limited | 2.59 Million AUD | 100.0% |
Arovella Therapeutics Limited | 17 Thousand AUD | 100.0% |
Anatara Lifesciences Ltd | - AUD | NaN% |
Alterity Therapeutics Limited | 4.01 Million AUD | 100.0% |
Amplia Therapeutics Limited | 4.45 Million AUD | 100.0% |
Avecho Biotechnology Limited | 473.55 Thousand AUD | 100.0% |
Bio-Gene Technology Limited | 18.32 Thousand AUD | 100.0% |
Biome Australia Limited | 13 Million AUD | 100.0% |
Biotron Limited | - AUD | NaN% |
Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | 100.0% |
BTC Health Limited | 16.36 Thousand AUD | 100.0% |
Chimeric Therapeutics Limited | 7.45 Million AUD | 100.0% |
CSL Limited | 22.41 Billion AUD | 100.0% |
Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 100.0% |
Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 100.0% |
Cynata Therapeutics Limited | 2.31 Million AUD | 100.0% |
Dimerix Limited | 583.47 Thousand AUD | 100.0% |
EZZ Life Science Holdings Limited | 66.44 Million AUD | 100.0% |
Hexima Limited | - AUD | NaN% |
Island Pharmaceuticals Limited | 1.25 Million AUD | 100.0% |
Immuron Limited | 4.9 Million AUD | 100.0% |
Immutep Limited | 3.5 Million AUD | 100.0% |
Invex Therapeutics Ltd | 1.21 Million AUD | 100.0% |
Memphasys Limited | 60 Thousand AUD | 100.0% |
Nanollose Limited | 12.5 Thousand AUD | 100.0% |
Neuren Pharmaceuticals Limited | 231.92 Million AUD | 100.0% |
Noxopharm Limited | 2.4 Million AUD | 100.0% |
NeuroScientific Biopharmaceuticals Limited | - AUD | NaN% |
Nyrada Inc. | - AUD | NaN% |
Orthocell Limited | 5.31 Million AUD | 100.0% |
PharmAust Limited | - AUD | NaN% |
Patrys Limited | 1.39 Million AUD | 100.0% |
Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | 100.0% |
Proteomics International Laboratories Limited | 892.14 Thousand AUD | 100.0% |
Prescient Therapeutics Limited | 3.71 Million AUD | 100.0% |
PYC Therapeutics Limited | 22.05 Million AUD | 100.0% |
Race Oncology Limited | 4 Million AUD | 100.0% |
Radiopharm Theranostics Limited | 299.22 Thousand AUD | 100.0% |
Recce Pharmaceuticals Ltd | - AUD | NaN% |
Starpharma Holdings Limited | 8.28 Million AUD | 100.0% |
Telix Pharmaceuticals Limited | 496.65 Million AUD | 100.0% |
Tissue Repair Ltd | 152.24 Thousand AUD | 100.0% |
Zelira Therapeutics Limited | 94.95 Thousand AUD | 100.0% |